Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.5778
-0.0022 (-0.38%)
Mar 5, 2026, 2:11 PM EST
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $38.67 million as of March 5, 2026. Its market cap has decreased by -55.79% in one year.
Market Cap
38.67M
Enterprise Value
40.59M
Revenue
115.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.58
Market Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has increased from 33.63M to 38.67M, an increase of 15.01%. That is a compound annual growth rate of 0.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 38.82M | -34.34% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HST Global | 70.56M |
| Nuo Therapeutics | 67.60M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 41.50M |
| ZIVO Bioscience | 37.00M |
| Harvard Apparatus Regenerative Technology | 30.24M |
| Finch Therapeutics Group | 21.28M |
| Provectus Biopharmaceuticals | 20.59M |